Peripheral levels of fibrinogen, c-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia

Psychosomatic Medicine

Volumn 71, Issue 8, 2009, Pages 901-906

  Marioni, Riccardo E ^a   Stewart, Marlene C ^a   Murray, Gordon D ^a   Deary, Ian J ^b   Fowkes, F Gerry R ^a   Lowe, Gordon D O ^c   Rumley, Ann ^c   Price, Jackie F ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cognition; Cognitive decline.; Inflammation; Rheology

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MILL HILL VOCABULARY SCALE; PLASMA VISCOSITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGIC ASSESSMENT; SCORING SYSTEM;

ASPIRIN; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD VISCOSITY; C-REACTIVE PROTEIN; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HEMATOCRIT; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PLASMA; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 70350129449     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3181b1e538     Document Type: Article

References (35)

1. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, McArdle JJ, Willis RJ, Wallace RB. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med 2008;148:427-434
2. Cheung RTF, Hachinski V. Vascular factors in cognitive decline. In: Fillit HM, Butler RN, editors. Cognitive Decline: Strategies for Prevention. Cambridge: University Press; 1997.
3. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia aging study. Ann Neurol 2002;52:168-174 (Pubitemid 34810596)
4. Jones RW. Inflammation and Alzheimer's disease. Lancet 2001;358: 436-437
5. Ravaglia G, Forti P, Maioli F, Brunetti N, Martelli M, Servadei L, Bastagli L, Bianchin M, Mariani E. Serum C-reactive protein and cognitive function in healthy elderly Italian community dwellers. J Gerontol A Biol Sci Med Sci 2005;60:1017-1021
6. Weuve J, Ridker PM, Cook NR, Buring JE, Grodstein F. High-sensitivity C-reactive protein and cognitive function in older women. Epidemiology 2006;17:183-189
7. Schram MT, Euser SM, de Craen AJM, Witteman JC, Frolich M, Hofman A, Jolles J, Breteler MM, Westendorp RG. Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc 2007;55: 708-716
8. Dik MG, Jonker C, Hack CE, Smit JH, Comijs HC, Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005;64:1371-1377
9. Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Rumley A, Lowe GD, Fowkes FG. Cognitive decline and markers of inflammation and hemostasis: the Edinburgh artery study. J Am Geriatr Soc 2007;55: 700-707
10. Lowe GDO. Is sticky blood a treatable determinant of cognitive decline and of dementia? Age Ageing 2001;30:101-103
11. Price JF, Stewart MC, Douglas AF, Murray GD, Fowkes GF. Frequency of a low ankle brachial index in the general population by age, sex and deprivation: cross-sectional survey of 28,980 men and women. Eur J Car-diovasc Prev Rehabil 2008;15:370-375
12. Stewart MC, Deary IJ, Fowkes FG, Price JF. Relationship between lifetime smoking, smoking status at older age and human cognitive function. Neuroepidemiology 2006;26:83-92.
13. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FG, Lee AJ, Price JF, d'Agostino RB, Mu-rabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodŕiguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hed-blad B, Witteman JC, Breteler MM, Hunink MG, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J, McDermott MM. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300:197-208.
14. Heald CL, Fowkes FGR, Murray GD, Price JF. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 2006;189:61-69
15. Price JF, Stewart MC, Deary IJ, Murray GD, Sandercock P, Butcher I, Fowkes FGR. Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial. BMJ 2008;337:a1198.
16. Lezak MD. Neuropsychological Assessment. 3rd ed. Oxford: Oxford University Press; 1995.
17. Raven J, Raven JC, Court JH. Raven Manual: Standard Progressive Matrices. Oxford, UK: Oxford Psychologists Press; 1998.
18. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation; 1981.
19. Crawford JR, Deary IJ, Starr J, Whalley LJ. The NART as an index of prior intellectual functioning: a retrospective validity study covering a 66-year interval. Psychosom Med 2001;31:451-458
20. Deary IJ, Whalley LJ, Crawford JR. An "instantaneous" estimate of a lifetime's cognitive change. Intelligence 2004;32:113-119
21. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh artery study. Circulation 2007;115:2119-2127.
22. SPSS for Windows, Rel. 14.0.1. 2005. Chicago: SPSS.
23. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E. Variability and classification accuracy of serial high-sensitivity C-reac-tive protein measurements in healthy adults. Clin Chem 2001;47:444-450
24. Salthouse T. Aging and measures of processing speed. Biol Psychol 2000;54:35-54.
25. Elwood PC, Pickering J, Gallacher JE. Cognitive function and blood rheology: results from the Caerphilly cohort of older men. Age Ageing 2001;30:135-139
26. Emberson J, Whincup P, Morris R, Walker M, Lowe GD, Rumley A. Extent of regression dilution for established and novel coronary risk factors: results from the British regional heart study. Eur J Cardiovasc Prev Rehabil 2004;11:125-134
27. Koenig W, Sund M, Frohlich M, Lowel H, Hutchinson WL, Pepys MB. Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987. Am J Epidemiol 2003;158:357-364
28. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-1143
29. Breteler MMB, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study. BMJ 1994;308:1604-1608
30. Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D, Heiss G. Early-life and adult socioeconomic status and inflammatory risk markers in adulthood. Eur J Epidemiol. 2007;22:55-66.
31. Tabassum F, Kumari M, Rumley A, Lowe G, Power C, Strachan DP. Effects of socioeconomic position on inflammatory and hemostatic markers: a life-course analysis in the 1958 British birth cohort. Am J Epidemiol. 2008;167:1332-1341
32. Liu B, Hong J. Role of microglia in inflammation-mediated neurodegen-erative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 2003;304:1-7.
33. Pulanić D, Rudan I. The past decade: fibrinogen. Coll Anthropol 2005; 29:341-349
34. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endo-thelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978
35. McGeer PL, McGeer EG. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord 2003;10:S3-S7.